MySmarTrend
← Insider Monitor
Inhibrx Biosciences, Inc. logo
INBX

Inhibrx Biosciences, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Inhibrx Biosciences is a clinical-stage biopharmaceutical company developing biologic therapeutics, including multi-specific antibodies and antibody-drug conjugates, primarily for the treatment of cancer and other diseases.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
La Jolla, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
MANHARD KIMBERLYDirectorSell$58KSep 9, 2026
MANHARD KIMBERLYDirectorSell$58KSep 8, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for INBX.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable INBX activity by email

Free alerts for the insider and congressional trades worth watching.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.